BioArctic AB

56
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0010323311
SEK
319.40
15.4 (5.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
BioArctic AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-189.00
276.00
-11.00
-140.00
-86.00
112.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-62.00
13.00
24.00
-5.00
26.00
403.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-316.00
309.00
-31.00
-140.00
-92.00
327.00
Cash Flow from Investing Activities
205.00
-507.00
-12.00
-4.00
-12.00
-3.00
Cash Flow from Financing Activities
5.00
14.00
-2.00
-7.00
-6.00
-138.00
Net Cash Inflow / Outflow
-98.00
-193.00
-43.00
-151.00
-112.00
195.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
6.00
-10.00
4.00
0.00
-1.00
10.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of BioArctic AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
-189.519
4407
-4,596.00
-104.30%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-62.57
-180
118.00
65.24%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-316.332
7387
-7,703.00
-104.28%
Cash Flow from Investing Activities
205.633
-3075
3,280.00
106.69%
Cash Flow from Financing Activities
5.686
-4016
4,021.00
100.14%
Net Cash Inflow / Outflow
-98.639
235
-333.00
-141.97%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
6.374
-61
67.00
110.45%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -202.14% vs 1,078.87% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-316.33
309.69
-202.14%